SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Bionect
Bionect Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Bionect Spółka z Ograniczoną Odpowiedzialnością
Bionect Spółka z Ograniczoną Odpowiedzialnością (KRS 0000799653, NIP 5252798626) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. BIONECT operates in: Other retail sale in non-specialised stores (PKD 47.19.Z). Industry: Retail trade. The company has been listed in the National Court Register since August 14, 2019.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
47.19.ZOther retail sale in non-specialised stores
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Founded
August 14, 2019
6 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
47.19.Z
Other retail sale in non-specialised stores
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
N/A
Registry entries
4
latest: January 2, 2020
No KPI data - financial statements and valuation are unavailable for this company.
Rate business credibility - Bionect.
No ratings

News
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).

News
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
Latest reporting year
-
Available years
0
Filing entries
0
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
BIONECT's board has 1 member.
4 historical registry entries for Bionect
Registration in the Polish National Court Register
WA.XII NS-REJ.KRS/59621/19/351
Identifier change
WA.XII NS-REJ.KRS/59621/19/351/NIP
Identifier change
WA.XII NS-REJ.KRS/59621/19/351/REGON
Board change, Shareholder change, Primary PKD code change
WA.XII NS-REJ.KRS/91668/19/902
Competing companies or those operating in the same market segment as Bionect (in Warszawa, industry: Retail trade).
WARSZAWA· Retail trade
Revenue 2024: 537.3 M PLN
WARSZAWA· Retail trade
Revenue 2024: 290.1 M PLN
WARSZAWA· Retail trade
Revenue 2023: 229.9 M PLN
WARSZAWA· Retail trade
Revenue 2018: 143.4 M PLN
KOŁBIEL· Retail trade
Revenue 2024: 107.6 M PLN
PŁOCK· Retail trade
Revenue 2024: 102.6 M PLN